Medindia

X

VIASPACE Subsidiary Wins $750,000 Army Contract for Robotic Detection of Chemical Warfare Agents and Explosives

Monday, August 11, 2008 General News J E 4
Advertisement
PASADENA, Calif., Aug. 11 VIASPACE Inc.(OTC Bulletin Board: VSPC) subsidiary Ionfinity has been awarded a $750,000Phase II contract for its proposal entitled "Advanced Robotic Detection ofChemical Agents, Toxic Industrial Gases, and Improvised Explosive Devices(IED)s for Force Health Protection" submitted to the Army Small BusinessTechnology Transfer (STTR) Program. This competitively selected two yearcontract will result in a field demonstration of high sensitivity detectionand analysis capability for chemical agents and explosives that threaten USforces. In addition to developing products for the $55 Billion securityindustry, the new sensor technology is expected to have commercialapplications in environmental monitoring, agriculture and medicine.

Ionfinity's contract is to develop a novel chemical agent sensor through ajoint collaboration with NASA's Jet Propulsion Laboratory, Caltech, GeneralDynamics, Sionex, and Imaginative Technologies. This chemical sensor systemconsists of a new and powerful detector called a Differential MobilitySpectrometer, a novel "soft-ionization" method that does not fragment ormultiply-ionize sampled species, and a micro-gas chromatograph forconfirmation and enhanced detection capability. The goal of the effort is todemonstrate a commercialized prototype of an enhanced version of the GeneralDynamics JUNO(TM) system that is inexpensive, compact, totally integrated andvery rugged. The new detection and analysis system can be used to identifychemical & bio-warfare agents, industrial toxic gases, and chemical componentsof Improvised Explosive Devices in air, water or solids. It is designed to beintegrated with unmanned ground vehicles for medical force health protectionand combat casualty care missions. This device is targeted to detect chemicalsat parts per trillion (ppt) to low parts per billion (ppb) levels within 6seconds.

Ionfinity Chairman, Chief Operating Officer, and Principal Investigatorfor this effort, James Weiss, reports, "This new sensor will change theparadigm used for future chemical detection and analysis, making it much moreconvenient, sensitive, selective and timely."

About VIASPACE: Founded in 1998 with the objective of transforming provenspace and defense technologies from NASA and the Department of Defense intohardware and software solutions that solve today's complex problems, VIASPACEbenefits from important patent and software licenses from Caltech, whichmanages NASA's Jet Propulsion Laboratory. VIASPACE is located in PasadenaCalifornia. For more information, please see http://www.VIASPACE.com, orcontact Dr. Jan Vandersande, Director of Communications at 800-517-8050, orIR@VIASPACE.com.

This news release includes forward-looking statements. Theseforward-looking statements relate to future events or our future performanceand involve known and unknown risks, uncertainties and other factors that maycause our actual results, levels of activity, performance or achievements tobe materially different from any future results, levels of activity,performance or achievements expressed or implied by these forward-lookingstatements. Such factors include the risks outlined in our periodic filingswith the U.S. Securities and Exchange Commission, including our Annual Reporton Form 10-KSB for the fiscal year ended December 31, 2007, as well as generaleconomic and business conditions, the ability to acquire and develop specificprojects and technologies, the ability to fund operations, changes in consumerand business consumption habits, and other factors over which VIASPACE haslittle or no control.

SOURCE VIASPACE Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Merrimack Pharmaceuticals Initiates Enrollment in ...
S
S.C. Company PGBA Announces Contract Award with Fe...